Cyclosporine Treatment in Severe Gestational Pemphigoid

Visa fullständig post



Permalänk

http://hdl.handle.net/10138/161810

Citation

Huilaja , L , Makikallio , K , Hannula-Jouppi , K , Vakeva , L , Hook-Nikanne , J & Tasanen , K 2015 , ' Cyclosporine Treatment in Severe Gestational Pemphigoid ' , Acta Dermato-Venereologica , vol. 95 , no. 5 , pp. 593-595 . https://doi.org/10.2340/00015555-2032

Titel: Cyclosporine Treatment in Severe Gestational Pemphigoid
Författare: Huilaja, Laura; Makikallio, Kaarin; Hannula-Jouppi, Katariina; Vakeva, Liisa; Hook-Nikanne, Johanna; Tasanen, Kaisa
Upphovmannens organisation: Clinicum
Department of Dermatology, Allergology and Venereology
Datum: 2015
Språk: eng
Sidantal: 3
Tillhör serie: Acta Dermato-Venereologica
ISSN: 0001-5555
DOI: https://doi.org/10.2340/00015555-2032
Permanenta länken (URI): http://hdl.handle.net/10138/161810
Abstrakt: Gestational pemphigoid, a rare autoimmune skin disease typically occurring during pregnancy, is caused by autoantibodies against collagen XVII. Clinically it is characterised by severe itching followed by erythematous and bullous lesions of the skin. Topical or oral glucocorticoids usually relieve symptoms, but in more severe cases systemic immunosuppressive treatments are needed. Data on immunosuppressive medication controlling gestational pemphigoid are sparse. We report 3 intractable cases of gestational pemphigoid treated with cyclosporine.
Subject: pemphigoid gestationis
treatment
cyclosporine
LINKED-IMMUNOSORBENT-ASSAY
PUSTULAR PSORIASIS
PREGNANCY
MANAGEMENT
DERMATOSES
DIAGNOSIS
THERAPY
ANTIGEN
MILK
3121 General medicine, internal medicine and other clinical medicine
Referentgranskad: Ja
Användningsbegränsning: openAccess
Parallelpublicerad version: publishedVersion


Filer under denna titel

Totalt antal nerladdningar: Laddar...

Filer Storlek Format Granska
4334.pdf 600.5Kb PDF Granska/Öppna

Detta dokument registreras i samling:

Visa fullständig post